"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
| Descriptor ID |
D018450
|
| MeSH Number(s) |
C23.550.291.656
|
| Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1995 | 0 | 5 | 5 |
| 1996 | 0 | 11 | 11 |
| 1997 | 0 | 7 | 7 |
| 1998 | 0 | 12 | 12 |
| 1999 | 0 | 7 | 7 |
| 2000 | 0 | 20 | 20 |
| 2001 | 0 | 17 | 17 |
| 2002 | 0 | 23 | 23 |
| 2003 | 0 | 24 | 24 |
| 2004 | 0 | 38 | 38 |
| 2005 | 0 | 37 | 37 |
| 2006 | 0 | 51 | 51 |
| 2007 | 1 | 37 | 38 |
| 2008 | 0 | 44 | 44 |
| 2009 | 3 | 52 | 55 |
| 2010 | 2 | 50 | 52 |
| 2011 | 2 | 49 | 51 |
| 2012 | 2 | 56 | 58 |
| 2013 | 2 | 51 | 53 |
| 2014 | 3 | 55 | 58 |
| 2015 | 5 | 57 | 62 |
| 2016 | 3 | 51 | 54 |
| 2017 | 7 | 55 | 62 |
| 2018 | 9 | 66 | 75 |
| 2019 | 4 | 55 | 59 |
| 2020 | 3 | 52 | 55 |
| 2021 | 5 | 33 | 38 |
| 2022 | 0 | 24 | 24 |
| 2023 | 0 | 21 | 21 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
Risk factors for haemodynamic compromise in multisystem inflammatory syndrome in children: a multicentre retrospective study. Rheumatology (Oxford). 2023 08 01; 62(8):2829-2837.
-
Treatable traits: a comprehensive precision medicine approach in interstitial lung disease. Eur Respir J. 2023 07; 62(1).
-
Sub-1.4 cm3 capsule for detecting labile inflammatory biomarkers in situ. Nature. 2023 Aug; 620(7973):386-392.
-
Increased cardiovascular morbidity and mortality in patients with resistance to thyroid hormone. Lancet Diabetes Endocrinol. 2023 Sep; 11(9):628-629.
-
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023 06 13; 329(22):1934-1946.
-
Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression. Respir Res. 2023 May 31; 24(1):141.
-
Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21). BMC Med Res Methodol. 2023 05 25; 23(1):129.
-
A blood and bronchoalveolar lavage protein signature of rapid FEV1 decline in smoking-associated COPD. Sci Rep. 2023 05 22; 13(1):8228.
-
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial. Int J Radiat Oncol Biol Phys. 2023 10 01; 117(2):370-377.
-
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023 05 01; 77(5):1797-1835.